Lagevrio

MOLNUPIRAVIR treats mild to moderate COVID-19. It may help people who are at high risk of developing severe illness. This medication works by limiting the spread of the virus in your body. The FDA has allowed the emergency use of this medication.

With the Patient Assistance Program from Merck, you can receive your prescription at no cost if you are eligible. Your medication will be shipped to your doctor if you are approved.